methylprednisolone has been researched along with Cytokine Release Syndrome in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 19 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, M; Sharma, A | 1 |
| Bektaş, M; Özdemir, G | 1 |
| Chan, TM; Chang, ES; Wu, CE; Yu, HH | 1 |
| Aminkeng, F; Bharwani, LD; Chan, YH; Fairhurst, AM; Huang, Y; Mak, A; Tay, SH; Thian, YL; Toh, MMX; Vellayappan, BA; Wong, ASC | 1 |
| Chen, W; Deng, K; Deng, X; Fan, Q; He, R; Hu, F; Huang, H; Lan, Y; Li, F; Tan, Y; Wang, Y | 1 |
| Huang, J; Huang, Y; Liu, J; Shan, H; Zheng, X | 1 |
| Cai, S; Dong, L; Li, M; Sun, W | 1 |
| Chen, X; Hu, J; Li, Y; Luo, C; Zuo, X | 1 |
| Jiménez-Brítez, G; Ruiz, P; Soler, X | 1 |
| Gonzales-Zamora, JA; Quiroz, T; Vega, AD | 1 |
| Broglie, L; Dorrello, NV; Hijiya, N; Kaur, D; Pavisic, J; Phillips, L | 1 |
| Campi, I; Covelli, D; Currò, N; Fugazzola, L; Guastella, C; Lazzaroni, E; Muller, I; Palomba, A; Salvi, M; Soranna, D; Vannucchi, G; Zambon, A | 1 |
| Blázquez-Roselló, S; Castillo-Fernández, AM; Guillamón-Fernández, D; Jódar-Moreno, R; López Ruz, MÁ; López Zúñiga, MÁ; López-Vílchez, M; Martínez-Colmenero, J; Moreno-Moral, A; Moreno-Sánchez, JJ; Ocaña-Granados, A; Padilla-Moreno, FA; Pimentel-Villar, MA; Prior-Sánchez, I; Ramírez-Sánchez, C; Sanchez-Palop, M | 1 |
| Agis, H; Anders, S; Domanovits, H; Laggner, AN; Schmidt, R; Schnaubelt, S; Strassl, R; Tihanyi, D | 1 |
| Landewé, RBM; Mostard, RLM; Ramiro, S | 1 |
| Janssen, MTHF; Landewé, RBM; Magro-Checa, C; Mostard, RLM; Ramiro, S | 1 |
| Allwood, BW; Ayele, BT; Du Plessis, EM; Koegelenberg, CFN; Lalla, U; Louw, EH; Nortje, A; Nyasulu, PS; Parker, A; Taljaard, JJ | 1 |
| Banerjee, D; Bapte, M; Bhayani, K; Bhoite, K; Borse, R; Dravid, A; Harshe, A; Joshi, G; Kadam, S; Kalyani, S; Kashiva, R; Khan, Z; Khandelwal, S; Kodre, A; Laxmi, SS; Mahajan, U; Mane, D; Mane, M; Mehta, A; Memon, D; More, S; Patil, D; Pawar, M; Pawar, V; Pharande, R; Potdar, P; Raut, P; Reddy, MS; Shinde, R; Srivastava, S; Vishnu, PD | 1 |
| Fujii, K; Itoh, K; Kikuchi, T; Kondo, Y; Ryuzaki, M; Sekine, K; Toda, M; Yoshifuji, A | 1 |
3 review(s) available for methylprednisolone and Cytokine Release Syndrome
| Article | Year |
|---|---|
Acute respiratory distress syndrome associated with macrophage activation syndrome in systemic lupus erythematosus: A case report and literature review.
Topics: Antirheumatic Agents; Cytokine Release Syndrome; Cytokines; Dexamethasone; Humans; Interleukin 1 Receptor Antagonist Protein; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Methylprednisolone; Respiratory Distress Syndrome | 2022 |
Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature.
Topics: Aged; Antibodies, Monoclonal, Humanized; Biomarkers; Cytokine Release Syndrome; Fatal Outcome; Female; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Male; Methylprednisolone; Middle Aged; Neoplasms; Pulse Therapy, Drug; Retrospective Studies; Severity of Illness Index; Tertiary Care Centers; Treatment Outcome | 2022 |
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Aspergillosis; Aspergillus fumigatus; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; Cytokine Release Syndrome; Deprescriptions; Disease Progression; Dyspnea; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunocompromised Host; Immunosuppressive Agents; Interleukin-6; Leflunomide; Lung; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Oxygen Inhalation Therapy; Pandemics; Pneumocystis carinii; Pneumonia, Pneumocystis; Pneumonia, Viral; Pulmonary Aspergillosis; Recurrence; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |
16 other study(ies) available for methylprednisolone and Cytokine Release Syndrome
| Article | Year |
|---|---|
Case Report: Home-based Management of Severe COVID-19 with Low-dose Tofacitinib.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; COVID-19 Drug Treatment; Cytokine Release Syndrome; Cytokines; Enoxaparin; Female; Gene Expression Regulation; Humans; Methylprednisolone; Middle Aged; Piperidines; Prednisone; Pyrimidines; SARS-CoV-2 | 2021 |
Protracted or recurrent COVID-19 associated cytokine storm in a patient with chronic lymphocytic leukemia receiving rituximab-based chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; COVID-19; COVID-19 Drug Treatment; Cyclophosphamide; Cytokine Release Syndrome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Rituximab; Treatment Outcome | 2022 |
Kinetics of Severity Biomarkers and Immunological Features of Methylprednisolone Therapy for Severe COVID-19 Patients.
Topics: Biomarkers; C-Reactive Protein; COVID-19 Drug Treatment; Cytokine Release Syndrome; Cytokines; Humans; Kinetics; Methylprednisolone; SARS-CoV-2 | 2022 |
Successful use of methylprednisolone for treating severe COVID-19.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betacoronavirus; Child; Child, Preschool; China; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Drug Administration Schedule; Female; Humans; Infant; Male; Methylprednisolone; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severity of Illness Index; Treatment Outcome | 2020 |
Pulmonary fibrosis and cytokine release syndrome after hyperactivation with sintilimab.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Colonic Neoplasms; Cytokine Release Syndrome; Glucocorticoids; Humans; Immunotherapy; Indoles; Male; Methylprednisolone; Middle Aged; Pulmonary Fibrosis | 2020 |
[Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience].
Topics: Aged; Antibodies, Monoclonal, Humanized; Bacterial Infections; Betacoronavirus; Combined Modality Therapy; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Illness; Cytokine Release Syndrome; Diabetes Mellitus; Female; Humans; Hypertension; Length of Stay; Male; Methylprednisolone; Middle Aged; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Superinfection; Treatment Outcome | 2020 |
Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia.
Topics: Adolescent; Allopurinol; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Betacoronavirus; Combined Modality Therapy; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Daunorubicin; Fluid Therapy; Humans; Male; Methylprednisolone; Nitriles; Pandemics; Pneumonia, Viral; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; Pyrimidines; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Vincristine | 2020 |
Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy.
Topics: Adult; Cytokine Release Syndrome; Decompression, Surgical; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunologic Factors; Male; Methylprednisolone; Middle Aged; Optic Nerve Diseases; Quality of Life; Rituximab; Severity of Illness Index; Treatment Failure; Treatment Outcome | 2021 |
High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response.
Topics: Adrenal Cortex Hormones; Adult; Aged; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Dexamethasone; Female; Hospitalization; Humans; Inflammation; Male; Methylprednisolone; Middle Aged; Prospective Studies; SARS-CoV-2; Spain; Survival Rate | 2021 |
Hemophagocytic lymphohistiocytosis in COVID-19: Case reports of a stepwise approach.
Topics: Aged; Anti-Inflammatory Agents; Combined Modality Therapy; COVID-19; Critical Care; Cytokine Release Syndrome; Delayed Diagnosis; Fatal Outcome; Female; Humans; Immunoglobulin A; Immunoglobulin M; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Lymphohistiocytosis, Hemophagocytic; Male; Methylprednisolone; Middle Aged; Respiration, Artificial; SARS-CoV-2 | 2021 |
COVID-19-induced hyperinflammation, immunosuppression, recovery and survival: how causal inference may help draw robust conclusions.
Topics: Antibodies, Monoclonal, Humanized; C-Reactive Protein; Causality; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Glucocorticoids; Historically Controlled Study; Humans; Immunosuppressive Agents; Inflammation; Mediation Analysis; Methylprednisolone; Mortality; SARS-CoV-2; Survival Rate; Treatment Outcome | 2021 |
Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation.
Topics: Antibodies, Monoclonal, Humanized; Antibodies, Viral; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Humans; Immunosuppressive Agents; Methylprednisolone; SARS-CoV-2 | 2021 |
Corticosteroids in critical COVID-19: Are all corticosteroids equal?
Topics: Adult; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Dexamethasone; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Hydrocortisone; Intensive Care Units; Length of Stay; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Severity of Illness Index; Survival Rate | 2021 |
Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India.
Topics: Antibodies, Monoclonal, Humanized; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Dexamethasone; Drug Therapy, Combination; Female; Humans; India; Intensive Care Units; Length of Stay; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Treatment Outcome | 2021 |
Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Kidney Diseases; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Renal Dialysis; Retrospective Studies; Time Factors; Treatment Outcome | 2022 |